Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis

NCT03829917 is registered in ClinicalTrials.gov with Fundacion Nacional de Dermatologia as lead sponsor.

NCT NCT03829917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03829917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis
Lead sponsor
Fundacion Nacional de Dermatologia
Phase
Phase 2/3
Overall status
Completed
Start date
February 1, 2019
Completion date
December 31, 2020
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous leishmaniasis, american